KRAS and colorectal carcinoma: We performed a robust and detailed multivariable analysis that involves demographic and clinico-pathological data; histopathological features; and allelic frequencies of KRAS, NRAS, BRAF, and EGFR genetic mutations, which we used to generate a cluster model of CRC patients as a starting point for the improvement of targeted therapeutic strategies.